• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨细胞瘤合并继发性动脉瘤样骨囊肿更易发生术后复发:256 例回顾性研究。

Giant cell tumors combined with secondary aneurysmal bone cysts are more likely to develop postoperative recurrence: A retrospective study of 256 cases.

机构信息

Department of Orthopaedics, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

School of Public Health, Guangxi Medical University, Nanning, Guangxi, China.

出版信息

J Surg Oncol. 2019 Sep;120(3):359-365. doi: 10.1002/jso.25588. Epub 2019 Jun 20.

DOI:10.1002/jso.25588
PMID:31219620
Abstract

PURPOSE

The epidemiology and clinicopathology of aneurysmal bone cysts (ABCs) secondary to giant cell tumors of bone (GCTBs) have been well documented in the previous literature. However, reports on whether secondary ABCs could affect the postoperative recurrence of GCTBs are rare. This study analyzed the effects of secondary ABCs and other relevant clinical factors on the postoperative recurrence of GCTBs of the extremities.

METHODS

We retrospectively analyzed 256 cases of GCTBs of the extremities that were treated surgically at our institution. Among them, there were 60 patients diagnosed with GCTBs combined with secondary ABCs and 196 patients diagnosed with simple GCTBs. Intralesional curettage and tumor resection were performed in 136 and 120 cases, respectively. Univariate analysis, Kaplan-Meier survival analysis, and multivariate regression analysis were used to assess the factors for postoperative recurrence. The follow-up period was at least 24 months.

RESULTS

The total postoperative recurrence rate was 32%. The recurrence rate in the secondary ABCs group was significantly higher than that in the simple GCTBs group (53.3% vs 25.5%, P < 0.05). Curettage was associated with a higher recurrence rate than tumor resection (42.5% vs 20%, P < 0.05). Kaplan-Meier survival analysis showed that patients with GCTBs combined with secondary ABCs and who were treated by intralesional curettage had a decreased disease-free survival rate. The hazard ratio was 2.18 (95% confidence interval [CI], 1.15-4.13) for the group of GCTB combined with ABCs ( P = 0.01) and 1.97 (95% CI, 1.22-7.50) for the curettage group ( P = 0.01), respectively. Multivariate regression analysis revealed that the presence of secondary ABCs and curettage were independent factors for recurrence of GCTBs.

CONCLUSION

According to the results of this study, the presence of secondary ABCs is a potential risk factor for postoperative relapse of GCTBs.

摘要

目的

动脉瘤样骨囊肿(ABC)继发于骨巨细胞瘤(GCTB)的流行病学和临床病理学已在前人的文献中得到充分阐述。然而,关于继发性 ABC 是否会影响 GCTB 术后复发的报道却很少。本研究分析了继发性 ABC 和其他相关临床因素对四肢 GCTB 术后复发的影响。

方法

我们回顾性分析了在我院接受手术治疗的 256 例四肢 GCTB 患者。其中,60 例诊断为 GCTB 合并继发性 ABC,196 例诊断为单纯 GCTB。分别对 136 例和 120 例患者进行了病灶内刮除和肿瘤切除术。采用单因素分析、Kaplan-Meier 生存分析和多因素回归分析评估术后复发的相关因素。随访时间至少 24 个月。

结果

总的术后复发率为 32%。继发性 ABC 组的复发率明显高于单纯 GCTB 组(53.3%比 25.5%,P<0.05)。病灶内刮除术的复发率高于肿瘤切除术(42.5%比 20%,P<0.05)。Kaplan-Meier 生存分析显示,患有 GCTB 合并继发性 ABC 并接受病灶内刮除术治疗的患者,无病生存率降低。GCTB 合并 ABC 组的危险比为 2.18(95%置信区间[CI],1.15-4.13)(P=0.01),刮除术组的危险比为 1.97(95% CI,1.22-7.50)(P=0.01)。多因素回归分析显示,继发性 ABC 的存在和刮除术是 GCTB 复发的独立因素。

结论

根据本研究结果,继发性 ABC 的存在是 GCTB 术后复发的潜在危险因素。

相似文献

1
Giant cell tumors combined with secondary aneurysmal bone cysts are more likely to develop postoperative recurrence: A retrospective study of 256 cases.巨细胞瘤合并继发性动脉瘤样骨囊肿更易发生术后复发:256 例回顾性研究。
J Surg Oncol. 2019 Sep;120(3):359-365. doi: 10.1002/jso.25588. Epub 2019 Jun 20.
2
Recurrence Rates and Risk Factors for Primary Giant Cell Tumors around the Knee: A Multicentre Retrospective Study in China.膝关节周围原发性骨巨细胞瘤的复发率及危险因素:一项中国多中心回顾性研究
Sci Rep. 2016 Nov 9;6:36332. doi: 10.1038/srep36332.
3
Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.手术方法和软组织扩展是骨巨细胞瘤局部复发的潜在危险因素。
World J Surg Oncol. 2016 Apr 19;14:114. doi: 10.1186/s12957-016-0871-z.
4
Magnetic resonance feature of "paintbrush borders" sign as a novel way to predict recurrence of giant cell tumor of bone after curettage: a pilot study.“画笔边缘”征的磁共振特征作为预测骨巨细胞瘤刮除术后复发的新方法:一项初步研究
J Int Med Res. 2018 Feb;46(2):710-722. doi: 10.1177/0300060517720345. Epub 2017 Sep 12.
5
Risk factors of fracture following curettage for bone giant cell tumors of the extremities.四肢骨巨细胞瘤刮除术后骨折的危险因素。
BMC Musculoskelet Disord. 2022 May 19;23(1):477. doi: 10.1186/s12891-022-05447-x.
6
Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution.肢体巨大细胞瘤:单中心 621 例回顾性分析。
J Bone Joint Surg Am. 2012 Mar 7;94(5):461-7. doi: 10.2106/JBJS.J.01922.
7
Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.骨巨细胞瘤病灶内治疗后伴或不伴辅助治疗的局部复发情况。
J Bone Joint Surg Am. 2008 May;90(5):1060-7. doi: 10.2106/JBJS.D.02771.
8
[Clinical observation of surgical management for recurrent giant cell tumor of bone].[复发性骨巨细胞瘤外科治疗的临床观察]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2013 Jan;27(1):36-40.
9
Giant cell tumor of bone with secondary aneurysmal bone cyst does not have a higher risk of local recurrence.伴有继发性骨囊肿的骨巨细胞瘤不存在更高的局部复发风险。
J Surg Oncol. 2023 Aug;128(2):350-358. doi: 10.1002/jso.27283. Epub 2023 Apr 13.
10
Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).外周骨骨巨细胞瘤刮除治疗后局部复发:GSF-GETO(法国肉瘤和骨肿瘤研究组)的回顾性研究。
Orthop Traumatol Surg Res. 2013 Oct;99(6 Suppl):S313-8. doi: 10.1016/j.otsr.2013.07.006. Epub 2013 Aug 23.

引用本文的文献

1
Giant cell tumor of bone and secondary osteoarthritis.骨巨细胞瘤与继发性骨关节炎。
Heliyon. 2024 May 9;10(10):e30890. doi: 10.1016/j.heliyon.2024.e30890. eCollection 2024 May 30.
2
Current Concepts in the Treatment of Giant Cell Tumor of Bone: An Update.当前骨巨细胞瘤治疗的新理念:更新。
Curr Oncol. 2024 Apr 8;31(4):2112-2132. doi: 10.3390/curroncol31040157.
3
Single-Cell RNA Sequencing Reveals the Migration of Osteoclasts in Giant Cell Tumor of Bone.单细胞RNA测序揭示骨巨细胞瘤中破骨细胞的迁移
Front Oncol. 2021 Aug 24;11:715552. doi: 10.3389/fonc.2021.715552. eCollection 2021.
4
Current Concepts in the Treatment of Giant Cell Tumors of Bone.骨巨细胞瘤治疗的当前概念
Cancers (Basel). 2021 Jul 21;13(15):3647. doi: 10.3390/cancers13153647.
5
Preoperative CT for prediction of local recurrence after curettage of giant cell tumor of bone.术前CT对骨巨细胞瘤刮除术后局部复发的预测作用
J Bone Oncol. 2021 May 11;29:100366. doi: 10.1016/j.jbo.2021.100366. eCollection 2021 Aug.
6
The impact of curettage technique on local control in giant cell tumour of bone.刮除技术对骨巨细胞瘤局部控制的影响。
Int Orthop. 2021 Mar;45(3):779-789. doi: 10.1007/s00264-020-04860-y. Epub 2020 Oct 22.
7
[Treatment of giant cell tumor of bone around knee joint with three-dimensional printing personalized prosthesis].[三维打印个性化假体治疗膝关节周围骨巨细胞瘤]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020 Jun 15;34(6):751-755. doi: 10.7507/1002-1892.201909109.
8
Oncology and functional prognosis are both vital in the surgical treatment of RGCTs around the knee joint.肿瘤学和功能预后在膝关节周围生殖细胞肿瘤的外科治疗中都至关重要。
Am J Transl Res. 2020 Mar 15;12(3):1155-1165. eCollection 2020.